- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06048809
A Study to Evaluate the Effect of a Stannous Fluoride Toothpaste on the Oral Microbiome
A Randomised, Controlled, Examiner Blind, Methodology Development Study to Evaluate the Effect of a Stannous Fluoride Toothpaste on the Oral Microbiome
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Haleon Response Center
- Phone Number: +441932 95 95 00
- Email: ww.clinical-trial-register@haleon.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participant provision of a signed and dated informed consent document indicating that the participant has been informed of all pertinent aspects of the study before any assessment is performed.
- Participant is male or female who, at the time of screening, is aged 18-65 years, inclusive.
- Participant who is willing and able to comply with scheduled visits, sampling schedule, treatment plan and other study procedures.
- Participant, in the opinion of the investigator or medically qualified designee, in good general and mental health.
At Screening (Visit 1):
- Participant with at least 20 natural, permanent teeth (excluding 3rd molars).
- Participant with at least 40 evaluable surfaces.
- Overall mean Turesky Modified Quigley and Hein Plaque Index (TPI) score greater than or equal to (>=) 1.5.
- Participants with 10% less than (<) bleeding sites (BS) < 30%
Exclusion Criteria:
- A participant who is an employee of the investigational site, either directly involved in the conduct of the study or otherwise supervised by the investigator, or a member of their immediate family; or a sponsor employee directly involved in the conduct of the study or a member of their immediate family.
- A participant who has participated in other studies (including non-medicinal studies) involving investigational product(s) in the 30 days prior to study entry and/or who is participating in other studies during study participation.
- A participant with, in the opinion of the investigator or medically qualified designee, an acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator or medically qualified designee, would make the participant inappropriate for entry into this study.
- A participant with any medical/oral condition which, in the opinion of the investigator or medically qualified designee, could impact study outcomes (for example, oral dryness or could directly influence gingival bleeding).
- A participant taking daily doses of medication/having daily treatments which, in the opinion of the investigator or medically qualified designee, could impact study outcomes (for example, is causing oral dryness).
- A participant who is pregnant (self-reported; no pregnancy test required) or intending to become pregnant over the course of the study.
- A participant who is breastfeeding.
- A participant with known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.
- A participant who is unwilling or unable to comply with the Lifestyle Considerations described in this protocol.
- A participant who has difficulty complying with study procedures and examinations, such as excessive gagging during oral assessments.
- A participant who has had routine dental prophylaxis within 12 weeks of Screening.
- A participant who has undergone a tooth bleaching procedure (at-home or professional) within 8 weeks of Screening.
A participant with any of the following which, in the opinion of the investigator or medically qualified designee, could impact study outcomes or the oral health of the participants if they were to participate in the study:
- Severe gingivitis.
- Signs of active periodontal disease or who is receiving or has received treatment for periodontal disease (including surgery) within 12 months of Screening.
- Active caries.
- Evidence of gross intra-oral neglect or the need for extensive dental therapy.
- Restorations in a poor state of repair or metal fillings.
- Any dental condition (example, malalignment, overcrowding)
- High levels of extrinsic dental stain or calculus deposits.
A participant with the following:
- A tongue or lip piercing.
- Multiple dental implants which, in the opinion of the investigator or medically qualified designee, could impact study outcomes.
- Fixed bridge(s) or removable partial dentures.
- Has or has had fixed or removable orthodontic braces/bands or a fixed orthodontic retainer within 3 months of Screening.
- A participant who is unwilling to forgo use of an orthodontic retainer for the duration of the study, provided there would be no impact on the outcome of any previous, completed orthodontic treatment or the participant's well-being.
- Participant who is a current smoker or an ex-smoker who stopped within 6 months of Screening (Visit 1).
- Participant who is a currently user of recreational drugs (example, cannabis) within 6 months of Screening.
- Participant who currently uses smokeless forms of tobacco (example, chewing tobacco, nicotine-based e-cigarettes) within 6 months of Screening.
Visit 1 (Screening)
- A participant who has taken antibiotics within 4 weeks of Screening.
- Participant who has used an anti-bacterial mouthwash (example, chlorhexidine) or another oral care product within 2 weeks of Screening that, in the opinion of the investigator or dentally qualified designee, could affect plaque formation or gingival health.
Visit 2 (Baseline)
1. A participant who has taken antibiotics during the lead-in period (between Screening and Baseline).
- Participant with a recent history (within the last year) of alcohol or other substance abuse.
- A participant who has previously been enrolled in this study.
- Participant who, in the opinion of the investigator or medically qualified designee, should not participate in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Test Toothpaste
Participants will be instructed to brush their teeth with the test toothpaste (Sensodyne Repair and Protect containing 1100 parts per million [ppm] fluoride as SnF2) for 1-timed minute twice a day (morning and evening) in their usual manner for 6 weeks.
Participants will record each brushing in the diary provided.
|
Sensodyne Repair and Protect toothpaste containing 1100 ppm fluoride as SnF2.
|
Active Comparator: Reference Toothpaste
Participants will be instructed to brush their teeth with the reference toothpaste (Colgate Cavity Protection containing 1100 ppm fluoride as sodium monofluorophosphate [SMFP]) for 1-timed minute twice a day (morning and evening) in their usual manner for 6 weeks.
Participants will record each brushing in the diary provided.
|
Colgate Cavity Protection containing 1100 ppm fluoride as SMFP.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline in Relative Abundances of Bacterial Groups at Week 6 by Treatment
Time Frame: Baseline and Week 6
|
The overall oral bacterial composition and relative abundances of bacterial groups will be analysed using microbiome profiling.
It will include 4 types of analyses: Taxonomy assignment, Alpha diversity comparison (diversity within samples), Beta diversity comparison (diversity between samples), Differential abundance analysis.
Change from Baseline is defined as relative abundance at Week 6 minus relative abundance at Baseline.
|
Baseline and Week 6
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 300101
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Health
-
Fernanda Muñoz SepúlvedaSubvención Presidencial, Ministerio de Hacienda, Chile; Centro Interuniversitario... and other collaboratorsCompletedOral Health Knowledge | Oral Health Attitudes | Oral Health Self-efficacyChile
-
Academia Cearense de OdontologiaCompletedOral Health | Public Health | Diagnosis, OralBrazil
-
Designs for HealthRecruitingA Pilot Study of a Commercially-available Oil Rinse Product (PerioPull™) on Markers of Dental HealthOral HealthUnited States
-
Oral Health Center of Expertise Rogaland, NorwayUniversity of Bergen; University of Agder; University of Stavanger; Regional Research...Recruiting
-
I.M. Sechenov First Moscow State Medical UniversityCompleted
-
GlaxoSmithKlineCompleted
-
Mundipharma Manufacturing Pte Ltd.Singapore Polytechnic (SP)Completed
-
University of Wisconsin, MadisonWisconsin Alumni Research FoundationCompleted
-
The University of Hong KongFood and Health Bureau, Hong KongRecruiting
Clinical Trials on Stannous Fluoride Toothpaste (Sensodyne Repair and Protect)
-
University of PaviaCompletedDental Caries | Dental FillingsItaly
-
University of PaviaCompletedPeriodontal Diseases | Dental CariesItaly
-
Cairo UniversityUnknown
-
GlaxoSmithKlineCompleted
-
Colgate PalmoliveCompleted
-
HALEONActive, not recruiting
-
Colgate PalmoliveCompleted
-
HALEONActive, not recruiting
-
University of LeedsCompleted